Treatment of HIV-infected patients with a combination of efavirenz, nevirapine and nucleoside reverse transcriptase inhibitors

被引：1

作者：

Arranz-Caso, J

Gorgolas, M

Estrada, V

Garcia-Diaz, JD

机构：

[1] Hosp Univ Principe Asturias, Med Interna Serv, Unidad Enfermedades Infecc, Infect Dis Unit, Madrid 28805, Spain

[2] Fdn Jimenez Diaz, Infect Dis Unit, Madrid, Spain

[3] Hosp Clin Madrid, HIV Unit, Madrid, Spain

[4] Hosp Principe Asturias, Clin Res Unit, Alcala De Henares, Spain

来源：

HIV MEDICINE | 2004年 / 5卷 / 02期

关键词：

HIV infection; efavirenz; nevirapine;

D O I：

10.1111/j.1468-1293.2004.00192.x

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

[No abstract available]

引用

页码：128 / 129

页数：2

共 4 条

[1] Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure [J].

Antinori, A ;

Zaccarelli, M ;

Cingolani, A ;

Forbici, F ;

Rizzo, MG ;

Trotta, MP ;

Di Giambenedetto, S ;

Narciso, P ;

Ammassari, A ;

Girardi, E ;

De Luca, A ;

Perno, CF .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (12) :835-838

[2] Extent and importance of cross-resistance to efavirenz after nevirapine failure [J].

Casado, JL ;

Moreno, A ;

Hertogs, K ;

Dronda, F ;

Moreno, S .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (11) :771-775

[3]

VANLETH F, 2003, 10 C RETR OPP INF BO

[4]

VELDKAMP A, 2000, 7 C RETR OPP INF CHI

← 1 →